We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$96.1B
1-Year Est. Return
40.06%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.11%
AUM
$96.1B
AUM Growth
-$5.35B
(-5.3%)
Cap. Flow
-$9.3B
Cap. Flow
% of AUM
-9.68%
Top 10 Holdings %
Top 10 Hldgs %
25.19%
Holding
2,466
New
61
Increased
706
Reduced
1,474
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$647M |
| 2 |
Costco
COST
|
+$566M |
| 3 |
Applied Materials
AMAT
|
+$461M |
| 4 |
ORCL.PRD
Oracle Corp Preferred Stock Series D
ORCL.PRD
|
+$428M |
| 5 |
Netflix
NFLX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.23B |
| 2 |
Morgan Stanley
MS
|
+$365M |
| 3 |
3M
MMM
|
+$334M |
| 4 |
Eli Lilly
LLY
|
+$331M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$319M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.97% |
| 2 | Industrials | 9.78% |
| 3 | Healthcare | 8.58% |
| 4 | Financials | 7.5% |
| 5 | Consumer Discretionary | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Pacific Biosciences
PACB
$441M
| $66.2K | ﹤0.01% |
50,142
-1,406
| -3% | -$2.52K |
|
2177
ADC Therapeutics
ADCT
$134M
| $65.2K | ﹤0.01% |
17,395
+3,020
| +21% | +$11.9K |
|
2178
Altimmune
ALT
$583M
| $64.7K | ﹤0.01% |
21,011
+7,321
| +53% | +$31.1K |
|
2179
iHeartMedia
IHRT
$602M
| $64.2K | ﹤0.01% |
21,972
-711
| -3% | -$2.35K |
|
|
SFIX
2180
Stitch Fix
SFIX
$552M
| $64.1K | ﹤0.01% |
19,380
-541
| -3% | -$2.21K |
|
2181
N-able
NABL
$953M
| $64K | ﹤0.01% |
13,697
-423
| -3% | -$2.36K |
|
2182
Rapid7
RPD
$720M
| $63.9K | ﹤0.01% |
11,597
-247
| -2% | -$2.27K |
|
2183
Allogene Therapeutics
ALLO
$635M
| $63.4K | ﹤0.01% |
25,976
-876
| -3% | -$1.76K |
|
2184
Blend Labs
BLND
$482M
| $62.7K | ﹤0.01% |
36,868
-1,072
| -3% | -$2.29K |
|
|
OPTU
2185
Optimum Communications Inc
OPTU
$336M
| $62.3K | ﹤0.01% |
47,898
-1,585
| -3% | -$2.49K |
|
2186
Akebia Therapeutics
AKBA
$351M
| $61.7K | ﹤0.01% |
44,403
-1,752
| -4% | -$2.41K |
|
2187
Lexeo Therapeutics
LXEO
$330M
| $61.4K | ﹤0.01% |
10,705
-271
| -2% | -$1.92K |
|
|
EU
2188
enCore Energy
EU
$223M
| $61.4K | ﹤0.01% |
34,107
-1,037
| -3% | -$2.65K |
|
2189
Aclaris Therapeutics
ACRS
$772M
| $61.2K | ﹤0.01% |
16,311
-937
| -5% | -$3.16K |
|
2190
Verastem
VSTM
$500M
| $61.1K | ﹤0.01% |
+11,531
| New | +$71.1K |
|
2191
UWM Holdings
UWMC
$651M
| $60.9K | ﹤0.01% |
16,817
+3,753
| +29% | +$17.3K |
|
2192
Prime Medicine
PRME
$508M
| $60.4K | ﹤0.01% |
17,345
-146
| -0.8% | -$556 |
|
2193
American Battery Technology Co
ABAT
$292M
| $59.5K | ﹤0.01% |
21,309
+1,208
| +6% | +$4.66K |
|
2194
Richtech Robotics
RR
$371M
| $58.8K | ﹤0.01% |
28,142
+1,583
| +6% | +$4.87K |
|
2195
Granite Ridge Resources
GRNT
$632M
| $58.8K | ﹤0.01% |
10,009
-647
| -6% | -$3.25K |
|
2196
Maravai LifeSciences
MRVI
$947M
| $57.2K | ﹤0.01% |
20,221
-709
| -3% | -$2.4K |
|
|
NXDR
2197
Nextdoor Holdings
NXDR
$866M
| $55.6K | ﹤0.01% |
39,721
-1,327
| -3% | -$2.31K |
|
2198
ThredUp
TDUP
$801M
| $54K | ﹤0.01% |
16,476
-433
| -3% | -$2.01K |
|
|
BBBY
2199
Bed Bath & Beyond
BBBY
$530M
| $52.7K | ﹤0.01% |
11,352
| – | – |
|
2200
Digital Turbine
APPS
$1.15B
| $52.7K | ﹤0.01% |
18,287
-519
| -3% | -$2.23K |
|
Similar funds
VOYA Investment Management's Q1 2026 Portfolio in Review
As of Q1 2026, VOYA Investment Management held 2,466 positions worth $96.1B, down 5.3% from $101B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VOYA Investment Management withdrew a net $9.3B in Q1 2026, closing 118 positions and reducing 1,474 holdings. Its most notable exit was Invesco S&P 500 Equal Weight ETF, an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, VOYA Investment Management opened a new position in Oracle Corp Preferred Stock Series D worth $407M.
- VOYA Investment Management's largest Q1 2026 buy was Oracle Corp Preferred Stock Series D: 9,046,650 shares worth $407M.
- VOYA Investment Management added most to Johnson & Johnson in Q1 2026, an estimated $647M increase.
- VOYA Investment Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.23B.
- VOYA Investment Management fully exited Invesco S&P 500 Equal Weight ETF in Q1 2026, selling an estimated $219M.
- VOYA Investment Management's ten largest holdings make up 25% of its $96.1B portfolio in Q1 2026.
- VOYA Investment Management opened 61 new positions and closed 118 in Q1 2026.
- VOYA Investment Management's portfolio value fell 5.3% quarter-over-quarter to $96.1B.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.